These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile. Schubert AM; Sinani H; Schloss PD mBio; 2015 Jul; 6(4):e00974. PubMed ID: 26173701 [TBL] [Abstract][Full Text] [Related]
26. Novel therapies and preventative strategies for primary and recurrent Clostridium difficile infections. Dieterle MG; Rao K; Young VB Ann N Y Acad Sci; 2019 Jan; 1435(1):110-138. PubMed ID: 30238983 [TBL] [Abstract][Full Text] [Related]
27. The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Džunková M; D'Auria G; Xu H; Huang J; Duan Y; Moya A; Kelly CP; Chen X Front Cell Infect Microbiol; 2016; 6():119. PubMed ID: 27757389 [TBL] [Abstract][Full Text] [Related]
28. Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Ferreyra JA; Wu KJ; Hryckowian AJ; Bouley DM; Weimer BC; Sonnenburg JL Cell Host Microbe; 2014 Dec; 16(6):770-7. PubMed ID: 25498344 [TBL] [Abstract][Full Text] [Related]
29. Current understanding of antibiotic-associated dysbiosis and approaches for its management. Kesavelu D; Jog P Ther Adv Infect Dis; 2023; 10():20499361231154443. PubMed ID: 36860273 [TBL] [Abstract][Full Text] [Related]
30. Microbiota-based markers predictive of development of Clostridioides difficile infection. Berkell M; Mysara M; Xavier BB; van Werkhoven CH; Monsieurs P; Lammens C; Ducher A; Vehreschild MJGT; Goossens H; de Gunzburg J; Bonten MJM; Malhotra-Kumar S; Nat Commun; 2021 Apr; 12(1):2241. PubMed ID: 33854066 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation? Vemuri RC; Gundamaraju R; Shinde T; Eri R Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784 [TBL] [Abstract][Full Text] [Related]
33. Oral antibiotic use and chronic disease: long-term health impact beyond antimicrobial resistance and Queen J; Zhang J; Sears CL Gut Microbes; 2020 Jul; 11(4):1092-1103. PubMed ID: 32037950 [TBL] [Abstract][Full Text] [Related]
34. [Modulation of gut microbiota during alleviation of antibiotic-associated diarrhea with Zingiberis Rhizoma]. Zhang XQ; Zhang CE; Yu XH; Ma YQ; Li M; Duan XY; Ma ZJ Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(5):1316-1326. PubMed ID: 35343160 [TBL] [Abstract][Full Text] [Related]
35. Antibiotics, obesity and the link to microbes - what are we doing to our children? Turta O; Rautava S BMC Med; 2016 Apr; 14():57. PubMed ID: 27090219 [TBL] [Abstract][Full Text] [Related]
36. The role of a sequencing-based clinical intestinal screening test in patients at high-risk for Clostridium difficile and other pathogens: a case report. Hitschfeld M; Tovar E; Gupta S; Bik EM; Palmer C; Hoaglin MC; Almonacid DE; Richman J; Apte ZS J Med Case Rep; 2019 Jan; 13(1):9. PubMed ID: 30642394 [TBL] [Abstract][Full Text] [Related]
37. Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model. Hryckowian AJ; Van Treuren W; Smits SA; Davis NM; Gardner JO; Bouley DM; Sonnenburg JL Nat Microbiol; 2018 Jun; 3(6):662-669. PubMed ID: 29686297 [TBL] [Abstract][Full Text] [Related]
38. Antibiotics as both friends and foes of the human gut microbiome: The microbial community approach. Nogueira T; David PHC; Pothier J Drug Dev Res; 2019 Feb; 80(1):86-97. PubMed ID: 30370682 [TBL] [Abstract][Full Text] [Related]